Patrick joined Pappas Capital in 2019 as an Executive-in-Residence. He is a seasoned global executive with a proven track record of entrepreneurship, building winning cultures and growing companies small and large. He has a unique ability to create, shape and implement strategic agendas, and motivate diverse teams to achieve results beyond what was expected. Prior to joining Pappas Capital, Patrick founded Cohera Medical, Inc. and shepherded it through commercialization while successfully raising multiple rounds of financing, including from KKR. The company was previously named the Pittsburgh Technology Counsel Company of the Year and Patrick was honored as CEO of the Year. He was also a three-time Ernst and Young Entrepreneur of the Year finalist.
Patrick is now the Global Vice President and GM for IQVIA MedTech and is developing and growing the burgeoning MedTech practice. He was recently the Chairman of the Advanced Medical Technology Association (AdvaMed) Accel Board, the division within AdvaMed dedicated to the needs of smaller medical technology manufacturers. He enjoyed a successful tenure on the Executive Board of AdvaMed and has nurtured and developed strong relationships with the Fortune 500 Med Tech CEOs. Earlier in his career, Patrick spent over 15 years at Johnson & Johnson (J&J) in a variety of cross-functional and international assignments in the U.S. and Asia Pacific. His work using six-sigma to improve the Key Opinion Leaders experience garnered the J&J Corporate Standards of Leadership Award. He has frequently been invited to speak on entrepreneurship and company development at the MBA programs at Carnegie Mellon and the University of Pittsburgh Heinz School of Business.
Patrick has a passion and commitment to America’s military. Along with his classmates from West Point, he founded and is on the Executive Board of The Johnny Mac Soldiers Fund, which has raised over $32 million in college scholarships for Gold Star children.
United States Military Academy at West Point (BS in Foreign Area Studies)
© 2023 Pappas Capital, LLC. ALL RIGHTS RESERVED.